Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Elevar Therapeutics
Elevar Therapeutics
Elevar, Hengrui eye quick refile for PD-1 liver cancer combo after surprise FDA rejection
Fierce Pharma
Wed, 07/10/24 - 11:06 am
Elevar Therapeutics
Jiangsu Hengrui Pharmaceuticals
PD-1 agonists
camrelizumab
rivoceranib
liver cancer
FDA